NASDAQ:SNWV

Sanuwave Health (SNWV) Stock Price, News & Analysis

Sanuwave Health logo
$1.71 +0.01 (+0.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.68 -0.03 (-1.70%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Sanuwave Health Stock (NASDAQ:SNWV)

Advanced

Key Stats

Today's Range
$1.64
▼
$1.82
50-Day Range
$1.58
▼
$5.93
52-Week Range
$1.55
▼
$35.29
Volume
96,145 shs
Average Volume
133,211 shs
Market Capitalization
$14.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$47.00
Consensus Rating
Reduce

Company Overview

SANUWAVE Health, Inc. is a medical technology company that develops and commercializes noninvasive therapies using its proprietary pulsed acoustic cellular expression (PACE) technology. The company focuses primarily on wound care.

Its main product, dermaPACE, delivers acoustic waves to wound tissue and is used as an adjunct to standard care for diabetic foot ulcers. The U.S. Food and Drug Administration approved the device for this use in 2019.

SANUWAVE has also pursued applications of its PACE technology beyond diabetic foot ulcers. Its products and development efforts center on using acoustic energy in medical treatments, with wound care as the company’s principal commercial focus.

AI Generated. May Contain Errors.

Sanuwave Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

SNWV MarketRank™: 
1.552875442895 of 5 stars

Sanuwave Health scored higher than 31% of companies evaluated by MarketBeat, and ranked 1289th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sanuwave Health has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 2 sell ratings.

  • Upside Potential

    Sanuwave Health has a consensus price target of $47.00, representing about 2,648.5% upside from its current price of $1.71.

  • Amount of Analyst Coverage

    Sanuwave Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Sanuwave Health's stock forecast and price target.
  • Price to Book Value per Share Ratio

    Sanuwave Health has a P/B Ratio of 5.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.45% of the float of Sanuwave Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Sanuwave Health has a short interest ratio ("days to cover") of 5.76.
  • Change versus previous month

    Short interest in Sanuwave Health has recently decreased by 23.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Sanuwave Health does not currently pay a dividend.

  • Dividend Growth

    Sanuwave Health does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Sanuwave Health this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for SNWV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sanuwave Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.40% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sanuwave Health's insider trading history.
Receive SNWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanuwave Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNWV Stock News Headlines

Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this fall.tc pixel
Sanuwave Q3 Revenue Falls 24% to $8.6 Million
Sanuwave Announces Q3 FY2026 Financial Results
See More Headlines

SNWV Stock Analysis - Frequently Asked Questions

Sanuwave Health's stock was trading at $29.84 on January 1st, 2026. Since then, SNWV shares have decreased by 94.3% and is now trading at $1.71.

Sanuwave Health Inc. (NASDAQ:SNWV) issued its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by $0.17. The company earned $8.58 million during the quarter, compared to the consensus estimate of $13.75 million. Sanuwave Health had a trailing twelve-month return on equity of 113.13% and a net margin of 6.22%.
Read the conference call transcript
.

Sanuwave Health shares reverse split before market open on Friday, October 18th 2024.The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Sanuwave Health's top institutional shareholders include AWM Investment Company Inc. (4.97%), State Street Corp (0.36%), State of Alaska Department of Revenue (0.33%) and Goldman Sachs Group Inc. (0.29%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta.
View institutional ownership trends
.

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sanuwave Health investors own include Advanced Micro Devices (AMD), Exelixis (EXEL), Micron Technology (MU), Niagen Bioscience (NAGE), Netflix (NFLX), PayPal (PYPL) and Roku (ROKU).

Company Calendar

Last Earnings
11/10/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:SNWV
Previous Symbol
NASDAQ:SNWV
CIK
1417663
Employees
55
Year Founded
2005

Price Target and Rating

High Price Target
$47.00
Low Price Target
$47.00
Potential Upside/Downside
+2,648.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.81 million
Net Margins
6.22%
Pretax Margin
10.43%
Return on Equity
113.13%
Return on Assets
7.17%

Debt

Debt-to-Equity Ratio
4.01
Current Ratio
1.18
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$44.05 million
Price / Sales
0.33
Cash Flow
$1.71 per share
Price / Cash Flow
1.00
Book Value
$0.33 per share
Price / Book
5.18

Miscellaneous

Outstanding Shares
8,600,000
Free Float
7,363,000
Market Cap
$14.71 million
Optionable
N/A
Beta
1.47

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:SNWV) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners